Gosha-Jinki-Gan Recovers Spermatogenesis in Mice with Busulfan-Induced Aspermatogenesis
Authors:
- Ning QuNQNing Qu
- Miyuki KuramasuMKMiyuki Kuramasu
- Yoshie HirayanagiYHYoshie Hirayanagi
- Kenta NagahoriKNKenta Nagahori
- Shogo HayashiShogo Hayashi
- Yuki OgawaYOYuki Ogawa
- Hayato TerayamaHTHayato Terayama
- Kaori SuyamaKSKaori Suyama
- Munekazu NaitoMNMunekazu Naito
- Kou SakabeKSKou Sakabe
- Masahiro ItohMIMasahiro Itoh
Open Access
- 3 September 2018
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 19 (9) , 2606
Abstract
Busulfan is an anti-cancer chemotherapeutic drug and is often used as conditioning regimens prior to bone marrow transplant for treatment of chronic myelogenous leukemia. Male infertility, including spermatogenesis disturbance, is known to be one of the side effects of anticancer drugs. While hormone preparations and vitamin preparations are used for spermatogenesis disturbance, their therapeutic effects are low. Some traditional herbal medicines have been administered to improve spermatogenesis. In the present study, we administered Gosha-jinki-gan (TJ107; Tsumura Co., Ltd., Tokyo, Japan) to mice suffering from severe aspermatogenesis after busulfan treatment to determine whether TJ107 can recover spermatogenesis. Male 4-week-old C57BL/6J mice were administered a single intraperitoneal injection of busulfan, and they were then fed a normal diet for 60 days and then a TJ107 diet or TJ107-free normal diet for another 60 days. After busulfan treatment, the weight of the testes and the epididymal sperm count progressively decreased in the normal diet group. On the other hand, in the TJ107 group, these variables dramatically recovered at 120 days. These results suggest that busulfan-induced aspermatogenesis is irreversible if appropriate treatment is not administered. Supplementation of TJ107 can completely recover the injured seminiferous epithelium via normalization of the macrophage migration and reduction of the expressions of Tool-like receptor (TLR) 2 and TLR4, suggesting that TJ107 has a therapeutic effect on busulfan-induced aspermatogenesis.Keywords
This publication has 31 references indexed in Scilit:
- Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathyCancer Chemotherapy and Pharmacology, 2013
- Herbal Medicine Goshajinkigan Prevents Paclitaxel-Induced Mechanical Allodynia without Impairing Antitumor Activity of PaclitaxelEvidence-Based Complementary and Alternative Medicine, 2013
- Damaged spermatogenic cells induce inflammatory gene expression in mouse Sertoli cells through the activation of Toll-like receptors 2 and 4Molecular and Cellular Endocrinology, 2013
- Clinical Pharmacokinetics of CyclophosphamideClinical Pharmacokinetics, 2005
- Murine male germ cell apoptosis induced by busulfan treatment correlates with loss of c‐kit‐expression in a Fas/FasL‐ and p53‐independent mannerFEBS Letters, 2004
- Functional Assessment of Self-Renewal Activity of Male Germline Stem Cells Following Cytotoxic Damage and Serial Transplantation1Biology of Reproduction, 2003
- Effects of busulfan on murine spermatogenesis: cytotoxicity, sterility, sperm abnormalities, and dominant lethal mutationsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1987
- SPERMATOGENETIC CLONES DEVELOPING FROM REPOPULATING STEM CELLS SURVIVING A HIGH DOSE OF AN ALKYLATING AGENTCell Proliferation, 1975
- THE RECOVERY FROM VARIOUS GRADATIONS OF CELL LOSS IN THE MOUSE SEMINIFEROUS EPITHELIUM AND ITS IMPLICATIONS FOR THE SPERMATOGONIAL STEM CELL RENEWAL THEORYCell Proliferation, 1974
- BUSULFAN (1,4‐DIMETHANESULFONYLOXYBUTANE, MYLERAN): SUMMARY OF CLINICAL, RESULTSAnnals of the New York Academy of Sciences, 1958